The company will try to get the Komzifti QTc prolongation warning removed.
ApexOnco Front Page
Recent articles
It’s less about being fast, more about producing a better product.
Car-T therapies and ADCs feature among recent first-in-human study entrants.
The agency approved eight oncology products over the month.
Varegacestat’s pivotal study reads out imminently.
The group will take HRS-4642 into a Chinese phase 3 in first-line pancreatic cancer.
The pivotal Harmoni-GI3 study has started enrolling patients.
ASH and SABCS approach.
